NXQ yields 138.85% · JNJ yields 2.13%● Live data
📍 NXQ pulled ahead of the other in Year 1
Combined, NXQ + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NXQ + JNJ for your $10,000?
Nuveen Select Tax-Free Income Portfolio 2 is a diversified closed-end management investment company. The Fund's investment objective is that it seeks to provide current income and stable dividends, exempt from regular federal and designated state income taxes, where applicable, consistent with the preservation of capital by investing primarily in a portfolio of municipal obligations. The Fund's portfolio composition includes various sectors, such as tax obligation/limited, tax obligation/general, healthcare, transportation, consumer staples, the United States guaranteed and Other. The Fund's portfolio spans various states and territories, including California, Illinois, Texas, New Jersey, Colorado, Washington, Florida, Virginia, New York, Missouri, Iowa, Michigan, Minnesota, Nevada and Other. The Fund's investment advisor is Nuveen Fund Advisors, LLC, which is a subsidiary of Nuveen Investments, Inc. (Nuveen).
Full NXQ Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.